Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy

The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.

Pseudomonas aeruginosa and Staphylococcus aureus virulence factors as biomarkers of infection

Cureus, Incidence Trends and Epidemiology of Staphylococcus aureus Bacteremia: A Systematic Review of Population-Based Studies

View of Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans

Metabolites, Free Full-Text

Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy

Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients? - Abstract - Europe PMC

Redefining Staphylococcus aureus bacteremia: A structured approach guiding diagnostic and therapeutic management - ScienceDirect

Platelet P2Y12 signalling pathway in the dysregulated immune response during sepsis - Amoafo - British Journal of Pharmacology - Wiley Online Library

Phenotyping of Methicillin-Resistant Staphylococcus aureus Using a Ratiometric Sensor Array

Severe community-acquired pneumonia

Staphylococcus aureus Bacteremia in Adults

Frontiers Practice Summary of Antimicrobial Therapy for Commonly Encountered Conditions in the Neonatal Intensive Care Unit: A Canadian Perspective

Biomarkers for early stage of acute respiratory distress syndrome in septic patients: surfactant protein D and Clara cell protein – topic of research paper in Health sciences. Download scholarly article PDF and